Showing results (611-620 of 757) with videos related to
Sort By:
Pageof 76
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 1, 2021
Effects of canagliflozin versus finerenone on cardiorenal outcomes: exploratory post hoc analyses from FIDELIO-DKD compared to reported CREDENCE resultsRajiv Agarwal, Stefan D Anker, Gerasimos Filippatos, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 25, 2023
Association between CKD-MBD and mortality in older patients with advanced CKD-results from the EQUAL studyLorenza Magagnoli, Mario Cozzolino, Fergus J Caskey, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 2, 2011
Renal outcomes of agalsidase beta treatment for Fabry disease: role of proteinuria and timing of treatment initiationDavid G Warnock, Alberto Ortiz, Michael Mauer, et al.Kidney International Reports|February 19, 2019
Left Ventricular Structure in Patients With Mild-to-Moderate CKD-a Magnetic Resonance Imaging StudyMarkus P Schneider, Johannes B Scheppach, Ulrike Raff, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 3, 2015
Secreted frizzled-related protein 4 predicts progression of autosomal dominant polycystic kidney diseaseStefan Zschiedrich, Klemens Budde, Jens Nürnberger, et al.Clinical Kidney Journal|February 10, 2021
Effect of linagliptin versus placebo on cardiovascular and kidney outcomes in nephrotic-range proteinuria and type 2 diabetes: the CARMELINA randomized controlled trialChristoph Wanner, Mark E Cooper, Odd Erik Johansen, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 26, 2014
Use of vascular access for haemodialysis in Europe: a report from the ERA-EDTA RegistryMarlies Noordzij, Kitty J Jager, Sabine N van der Veer, et al.Clinical Kidney Journal|September 3, 2021
Erratum to: Effect of linagliptin versus placebo on cardiovascular and kidney outcomes in nephrotic-range proteinuria and type 2 diabetes (t2d): the carmelina randomised controlled trialChristoph Wanner, Mark E Cooper, Odd Erik Johansen, et al.The American Journal of Clinical Nutrition|September 27, 2022
The association between TMAO, CMPF, and clinical outcomes in advanced chronic kidney disease: results from the European QUALity (EQUAL) StudyLu Dai, Ziad A Massy, Peter Stenvinkel, et al.Journal of the American Society of Nephrology : JASN|July 12, 2019
GFR Slope as a Surrogate End Point for Kidney Disease Progression in Clinical Trials: A Meta-Analysis of Treatment Effects of Randomized Controlled TrialsLesley A Inker, Hiddo J L Heerspink, Hocine Tighiouart, et al.Pageof 76